A Phase 1 Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group/Crossover Thorough QT/QTc Study to Evaluate the Effect of a Therapeutic Dose and a Supra-Therapeutic Dose of VI-0521 on Cardiac Repolarization in Healthy Male and Female Volunteers.
Phase of Trial: Phase I
Latest Information Update: 22 Jan 2010
At a glance
- Drugs Moxifloxacin; Phentermine/topiramate
- Indications Bacterial infections
- Focus Adverse reactions
- Sponsors VIVUS
- 21 Jan 2010 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 21 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.